SMTL ID : 5yu9.1 (3 other biounits)

Crystal structure of EGFR 696-1022 T790M in complex with Ibrutinib

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.95 Å

Oligo State

monomer

Ligands

1 x 1E8: 1-{(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl}prop-2-en-1-one(Covalent)

1E8.1: 16 residues within 4Å: Chain A: L.27, G.28, V.35, A.52, K.54, M.75, L.97, M.99, Q.100, M.102, C.106, R.150, L.153, T.163, D.164, F.165 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:L.27, A:V.35, A:A.52, A:K.54, A:L.97, A:R.150, A:L.153 Hydrogen bonds: A:Q.100, A:M.102

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wang, A. et al., Ibrutinib targets mutant-EGFR kinase with a distinct binding conformation. Oncotarget (2016)

Release Date

2017-12-27

Peptides

Epidermal growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Epidermal growth factor receptor

Related Entries With Identical Sequence